Most Recent

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

0 Comments

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.

0 Comments

image: Opinion: Pay-to-Play Publishing

Opinion: Pay-to-Play Publishing

By | September 3, 2015

Online scientific journals are sacrificing the quality of research articles to make a buck.

2 Comments

image: Opinion: Making Progress by Slowing Down

Opinion: Making Progress by Slowing Down

By | August 24, 2015

Academic research could be strengthened by thinking more and doing less.

5 Comments

While some in the scientific and religious communities have declared an end to the tensions between faith and fact, the conflict continues to have impacts on health, politics, and the environment.

28 Comments

image: Opinion: Academic Waste

Opinion: Academic Waste

By | October 17, 2013

From funding to publishing, academic research needlessly burns through time and money.

3 Comments

image: Opinion: Making Room for Rising Stars

Opinion: Making Room for Rising Stars

By | September 4, 2013

Dealing with the delicate matter of retirement for aging academics

7 Comments

image: Opinion: Restoring Tomato Flavor

Opinion: Restoring Tomato Flavor

By | August 28, 2013

Commercial tomatoes rarely have that fresh vine-ripened flavor that everyone loves, but the ideal recipe for tomato taste is now known. Will growers embrace the new cultivars?

4 Comments

image: Opinion: Going International

Opinion: Going International

By and | June 10, 2013

US universities need to reach across their own borders to retain global scientific preeminence.

0 Comments

image: Opinion: The Dilemma of Diversity

Opinion: The Dilemma of Diversity

By | June 10, 2013

The NIH remains a Caucasian-dominated workforce. Why haven’t the agency’s efforts to diversify been successful?

3 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech